查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014450

DNA和RNA樣品製備市場：按產品類型、技術、應用和最終用戶分類的全球市場預測—2026-2032年

DNA-RNA Sample Preparation Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，DNA 和 RNA 樣品製備市場價值將達到 24.2 億美元，到 2026 年將成長到 26.3 億美元，到 2032 年將達到 45.6 億美元，複合年成長率為 9.49%。

主要市場統計數據
基準年 2025 24.2億美元
預計年份：2026年 26.3億美元
預測年份 2032 45.6億美元
複合年成長率 (%) 9.49%

這本權威的入門書籍說明了DNA 和 RNA 樣本製備如何支撐現代生命科學工作流程中的實驗室可靠性、提高通量和符合監管要求。

DNA和RNA樣本製備是現代生命科學工作流程的基礎，對診斷、治療方法開發和基礎研究的成果至關重要。實驗室面臨越來越大的壓力，需要在控制成本和滿足監管要求的同時，實現更高的通量、更好的重複性和可追溯的監管鏈。因此，樣本製備已從簡單的常規實驗步驟演變為影響定序、分子診斷和生物標記發現等下游流程成功與否的關鍵因素。

自動化、試劑化學的進步、檢測的去中心化以及數位化工作流程的整合正在改變世界各地實驗室的核酸樣本製備方法。

技術創新、操作需求和不斷變化的法規共同作用，正在重塑樣本製備流程，並改變實驗室處理核酸的方式。自動化不再是僅限於高通量中心的專屬功能，而是各機構尋求降低變異性、提高處理能力並將技術人員重新分配到更高價值任務的策略重點。自動化工作站和整合平台簡化了從提取到樣品製備的工作流程，從而為定序和診斷檢測提供更一致的輸入材料。

該評估旨在評估美國關稅政策和貿易趨勢的變化如何影響樣品製備業務的採購韌性、供應商策略和業務連續性。

美國關稅政策和貿易措施日益凸顯了整個生命科學生態系統對具有韌性的供應鏈和彈性籌資策略的需求。關稅結構的變化會影響儀器、試劑盒和試劑的採購成本，並影響庫存策略、供應商多元化和本地製造夥伴關係等方面的決策。對於依賴及時交貨和檢驗樣本的實驗室而言，關稅引發的成本轉移可能會擾亂採購週期，並迫使其重新談判供應商合約。

詳細的細分洞察揭示了儀器、試劑盒和試劑的化學特性、核心技術、多樣化的應用以及不同的最終用戶如何決定不同的採購和驗證優先事項。

對產品細分的詳細分析闡明了效能提升與採購複雜性之間的交集。產品類型包括儀器、試劑盒和試劑。儀器包括自動化工作站和離心機，它們在處理能力、面積和整合潛力方面差異顯著。試劑盒包括樣品製備盒和核酸萃取試劑盒，其中樣品製備盒可進一步細分為DNA文庫建構試劑盒和RNA文庫建構試劑盒，二者對酵素處理和操作的要求各不相同。試劑包括緩衝液和酶，它們各自具有獨特的化學性質，這些性質決定了產量、完整性以及與下游檢測的兼容性。了解這些差異對於根據工作流程目標和驗證限制客製化採購至關重要。

美洲、歐洲、中東和非洲以及亞太地區的地理差異如何決定樣品製備解決方案的採購重點、驗證需求和區域市場進入策略。

區域趨勢在塑造供應鏈、監管預期以及樣本製備技術的普及率方面發揮決定性作用。在美洲，先進的臨床檢查室和研究機構的集中，以及強大的生物技術產業，正在推動對高通量自動化和經驗證試劑盒的需求。同時，籌資策略強調與夥伴關係建立夥伴關係並遵守區域監管要求。此外，美洲正在積極投資本地生產和分銷網路，以支援快速部署並應對關稅和物流方面的複雜性。

競爭格局分析表明，平台整合、化學差異化、本地支援和策略夥伴關係關係如何決定供應商的優勢和客戶的偏好。

DNA和RNA樣本製備生態系統的競爭動態是由成熟的儀器製造商、專業的試劑供應商和敏捷的試劑盒開發商共同塑造的。領導企業專注於平台整合、自動化功能和軟體驅動的工作流程管理，而試劑和試劑盒供應商則透過化學創新、易用性和針對特定應用（例如臨床診斷和法醫學分析）的驗證支援來脫穎而出。儀器和耗材供應商之間的策略合作和共同開發契約日益普遍，從而打造出能夠簡化驗證並加速部署的捆綁式解決方案。

為供應商和檢查室管理人員提供切實可行的策略建議，以增強韌性、簡化驗證流程並加速採用先進的樣品製備解決方案。

產業領導者應優先考慮能夠增強營運韌性、促進技術互通性並降低終端用戶驗證門檻的策略。首先，投資於支援多種萃取和樣品製備化學反應的模組化自動化平台，可以讓客戶在無需完全更換硬體的情況下調整工作流程，從而保護現有部署並降低採購門檻。這種模組化設計應輔以開放介面和軟體API，以簡化與實驗室資訊系統和分析流程的整合。

高度透明且嚴格三角驗證的調查方法，結合訪談、技術評估、文獻回顧和比較評估，確保了實用可靠的見解。

本分析整合了第一手和第二手調查、技術文獻以及相關人員訪談，旨在建構對DNA和RNA樣本製備實際情況的實證理解。主要資訊來源包括對臨床、法醫學和研究領域的檢查室管理人員、採購負責人和產品專家的結構化訪談，以及對典型工作流程中儀器性能和試劑穩定性的技術評估。這些訪談資料輔以對同儕審查文獻和監管指南的全面審查，以確保與當前的最佳實踐和合規要求保持一致。

摘要強調了穩健、互通性和檢驗的樣本製備技術對於支持可靠的基因組分析和診斷結果的戰略重要性。

簡而言之，DNA和RNA樣本製備不再只是一項檢查室工作，而是一個策略性領域，它對下游基因組分析和診斷流程的品質、速度和成本效益有顯著影響。自動化和試劑化學領域的技術進步不斷拓展著相關能力，同時也提高了人們對供應連續性、檢驗支援以及與數位化檢查室生態系統整合的期望。因此，供應商和最終用戶都必須採取全面的觀點，優先考慮互通性、可追溯性和可靠性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：DNA/RNA樣品製備市場：依產品類型分類

  • 裝置
    • 自動化工作站
    • 離心機
  • 成套工具
    • 樣品製備工具包
      • DNA文庫建構試劑盒
      • RNA文庫建構試劑盒
    • 核酸萃取試劑盒
  • 試劑
    • 緩衝
    • 酵素

第9章：DNA/RNA樣品製備市場：依技術分類

  • 列式法
  • 磁選
  • 降水法

第10章：DNA/RNA樣品製備市場：依應用領域分類

  • 臨床診斷
    • 基因檢測
    • 感染疾病
  • 法醫學
    • DNA指紋圖譜
    • RNA分析
  • 研究
    • 基因組學
    • 轉錄組學

第11章 DNA/RNA 樣本製備市場：依最終用戶分類

  • 學術機構
    • 研究機構
    • 大學
  • 生技公司
    • 生物製藥公司
    • 生技Start-Ups
  • 醫院
    • 臨床檢查室
    • 診斷中心
  • 製藥公司
    • 大型製藥企業
    • 學名藥公司

第12章：DNA/RNA樣品製備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：DNA/RNA樣品製備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 DNA/RNA 樣本製備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國DNA/RNA樣本製備市場

第16章：中國DNA與RNA樣本製備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies, Inc.
  • Akonni Biosystems, Inc.
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Merck KGaA
  • New England Biolabs, Inc.
  • Norgen Biotek Corp.
  • Omega Bio-tek, Inc.
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN NV
  • Sage Science, Inc.
  • Takara Bio Inc.
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-4348D129FA47

The DNA-RNA Sample Preparation Market was valued at USD 2.42 billion in 2025 and is projected to grow to USD 2.63 billion in 2026, with a CAGR of 9.49%, reaching USD 4.56 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.42 billion
Estimated Year [2026] USD 2.63 billion
Forecast Year [2032] USD 4.56 billion
CAGR (%) 9.49%

An authoritative primer on how DNA and RNA sample preparation now underpins laboratory reliability, throughput scaling, and regulatory compliance across modern life science workflows

The preparation of DNA and RNA samples is foundational to modern life sciences workflows, driving outcomes in diagnostics, therapeutics development, and basic research. Laboratories are increasingly pressured to deliver higher throughput, greater reproducibility, and traceable chain-of-custody while managing cost and regulatory requirements. As a result, sample preparation has evolved from a routine laboratory step into a critical enabler of downstream success for sequencing, molecular diagnostics, and biomarker discovery.

Across clinical and research settings, the demand for streamlined procedures and automation has intensified. Technological advances in enzymology, buffer chemistry, and extraction hardware have reduced hands-on time and variability, yet they have also introduced new considerations around compatibility, validation, and operator training. In parallel, regulatory scrutiny and quality management expectations are extending into pre-analytical stages, prompting procurement and operations teams to rethink vendor selection, validation protocols, and supply continuity.

This introduction frames the subsequent analysis by highlighting the operational and strategic levers available to laboratory leaders. It underscores the interplay between instrumentation, consumable design, and workflow integration, and points to the need for a nuanced evaluation that balances performance, total cost of ownership, and future-proofing against technological shifts. The following sections expand on these themes, offering insight into the transformative forces reshaping sample preparation and practical implications for decision-makers.

How automation, reagent chemistry advances, decentralization of testing, and digital workflow integration are collectively transforming nucleic acid sample preparation practices in laboratories worldwide

Sample preparation is being reshaped by a convergence of technological innovation, operational demand, and regulatory evolution that together are driving transformational change in how laboratories approach nucleic acid handling. Automation is no longer a niche capability reserved for high-throughput centers; instead, it has become a strategic priority for institutions seeking to reduce variability, increase throughput, and redeploy skilled staff toward higher-value tasks. Automated workstations and integrated platforms are streamlining workflows from extraction through library preparation, enabling more consistent input material for sequencing and diagnostic assays.

Concurrently, chemistry and reagent advances are improving yield and integrity of nucleic acids extracted from challenging specimen types, extending the range of samples that can be processed reliably. Innovations in buffer formulations and enzyme engineering are driving faster protocols and greater resilience to inhibitors, which translates into improved downstream performance for both genomic and transcriptomic applications. These gains are complemented by methodological refinement in library preparation approaches, where automation-compatible kits and modular protocols are shortening turnaround time and simplifying validation.

Another significant shift is the decentralization of testing capabilities. Point-of-care and near-patient diagnostics, coupled with distributed research networks, are increasing demand for simplified, ruggedized sample preparation solutions that can operate reliably outside centralized laboratories. This trend is prompting suppliers to develop compact instruments and pre-formulated reagents that minimize user-dependent variability.

Finally, digital integration and data provenance are becoming intrinsic to sample preparation strategy. Workflow-aware software, sample tracking, and connectivity to laboratory information management systems are enhancing traceability and enabling continuous improvement. As a result, organizations are prioritizing vendors and platforms that offer not just performance but an ecosystem approach that aligns instrumentation, consumables, and software to deliver reproducible results and operational visibility.

Assessing how evolving tariff policies and trade dynamics in the United States are reshaping procurement resilience, supplier strategies, and operational continuity for sample preparation operations

Tariff policies and trade actions in the United States have amplified the need for resilient supply chains and adaptive sourcing strategies across the life sciences ecosystem. Changes in tariff structures affect the economics of procuring instruments, kits, and reagents, and they influence decisions regarding inventory strategy, vendor diversification, and localized manufacturing partnerships. For laboratories dependent on timely deliveries and validated inputs, tariff-driven cost shifts can disrupt procurement cycles and necessitate renegotiation of supplier agreements.

The cumulative impact of tariff adjustments is felt most acutely by organizations operating with lean inventory models and by small or emerging suppliers who may have limited ability to absorb added costs. In response, many buyers have sought to re-evaluate vendor contracts to incorporate price escalation clauses, extended lead times, and contingency provisions. At the same time, purchasing teams and operational leaders are exploring near-shoring and multi-sourcing arrangements to mitigate exposure to single-country production risks and customs delays.

Another consequence of tariff dynamics is accelerated interest in alternative product architectures and technologies that offer comparable performance with different supply pathways. For example, labs may consider switching between column-based extraction and magnetic separation chemistries if one route demonstrates superior availability or shorter lead times. This procurement flexibility must be balanced against validation burdens and clinical equivalence requirements, particularly in regulated diagnostic environments.

Importantly, tariff-induced cost pressures also incentivize greater collaboration between vendors and end users. Long-term supply agreements, joint inventory planning, and strategic stock buffering are becoming more common as stakeholders seek stability. These approaches, combined with an increased focus on supplier risk assessment, help laboratories maintain continuity of operations while navigating evolving trade conditions and protecting quality and compliance standards.

Deep segmentation insights revealing how instruments, kits, reagent chemistries, core technologies, varied applications, and heterogeneous end users drive differentiated procurement and validation priorities

A granular view of product segmentation clarifies where performance improvements and procurement complexity intersect. Product categories encompass instruments, kits, and reagents, with instruments including automated workstations and centrifuges that differ significantly in throughput, footprint, and integration potential. Kits cover library preparation kits and nucleic acid extraction kits, with library preparation further split into DNA and RNA library kits that have distinct enzymatic and handling requirements. Reagents span buffers and enzymes, the discrete chemistries that determine yield, integrity, and compatibility with downstream assays. Understanding these distinctions is essential for aligning procurement to workflow objectives and validation constraints.

Technological segmentation highlights the fundamental mechanisms by which nucleic acids are isolated and purified. Column-based methods remain prevalent for specific sample types due to their simplicity and familiarity, whereas magnetic separation has gained favor for automation and scalability because it is readily integrated into robotic workflows. Precipitation techniques retain utility for certain applications where cost-effectiveness and simplicity are prioritized. Each technology path brings trade-offs in terms of hands-on time, equipment compatibility, and susceptibility to inhibitors, therefore technology choice should be informed by sample type, throughput needs, and downstream analytics.

Application-based segmentation emphasizes the diversity of end-use requirements. Clinical diagnostics require stringent validation and reproducibility, with subdomains in genetic testing and infectious disease detection demanding reliable nucleic acid recovery and regulatory traceability. Forensics workflows focus on DNA fingerprinting and RNA analysis with particular attention to sample preservation and chain-of-custody, while research applications in genomics and transcriptomics often prioritize flexibility, sensitivity, and the ability to handle novel or degraded samples. These application distinctions drive different performance specifications and consumable formats.

End-user segmentation reveals divergent purchasing behaviors and validation priorities. Academic institutes, comprising research institutions and universities, typically prioritize flexibility and cost-effectiveness for exploratory work, whereas biotechnology companies-spanning biopharma firms and biotech startups-require scalable, reproducible solutions that support product development timelines. Hospitals, including clinical labs and diagnostic centers, demand validated, regulatory-compliant kits and workflows with predictable supply. Pharmaceutical companies, both major firms and generic manufacturers, emphasize consistency, batch control, and supplier reliability to support clinical trials and manufacturing processes. Recognizing these end-user characteristics allows suppliers to tailor product portfolios, support services, and validation packages to the needs of distinct customer segments.

How geographic differences across the Americas, EMEA, and Asia-Pacific determine procurement priorities, validation needs, and regional go-to-market approaches for sample preparation solutions

Regional dynamics play a decisive role in shaping supply chains, regulatory expectations, and adoption rates for sample preparation technologies. In the Americas, a concentration of advanced clinical laboratories, research institutions, and a strong biotech sector drives demand for high-throughput automation and validated kits, while procurement strategies emphasize supplier partnerships and regulatory compliance that aligns with regional agencies. The Americas also exhibits active investment in localized manufacturing and distribution networks to support rapid deployment and to manage tariff and logistics complexity.

Europe, the Middle East, and Africa present a heterogeneous landscape where regulatory harmonization across certain countries contrasts with highly localized procurement practices in others. This region demonstrates strong demand for flexible solutions that can meet diverse regulatory requirements and operate across varying laboratory infrastructures. Moreover, EMEA institutions are increasingly focused on sustainability, cold-chain optimization, and vendor transparency, which influences purchasing decisions related to consumable waste reduction and supply chain traceability.

Asia-Pacific continues to be characterized by rapid adoption of automation and a growing base of domestic manufacturers and suppliers. High-volume research initiatives, expanding clinical testing capacity, and substantial public investment in genomics and precision medicine accelerate uptake of both instruments and consumables. However, regional diversity in regulatory frameworks and specimen types necessitates tailored validation support and localized customer training programs. Collectively, these geographic distinctions underscore the importance of regionalized go-to-market strategies, flexible distribution models, and robust local technical support to ensure successful implementation and sustained usage across different territories.

Competitive landscape analysis showing how platform integration, chemistry differentiation, localized support, and strategic partnerships determine supplier strength and customer preference

Competitive dynamics within the DNA and RNA sample preparation ecosystem are defined by a mix of established instrument manufacturers, specialized reagent suppliers, and agile kit developers. Leaders in instrumentation concentrate on platform integration, automation capabilities, and software-enabled workflow management, while reagent and kit providers differentiate through chemistry innovation, ease-of-use, and validation support for specific applications such as clinical diagnostics or forensic analysis. Strategic alliances and co-development agreements between instrument and consumable vendors are increasingly common, creating bundled solutions that simplify validation and accelerate adoption.

Smaller, focused entrants often compete by offering niche chemistry advantages, lower-cost consumables, or highly specialized kits optimized for particular specimen types or downstream assays. These suppliers can be attractive partners for research institutions seeking novel performance characteristics or for organizations aiming to reduce dependency on single-source providers. At the same time, established suppliers leverage scale to provide extended service networks, regulatory documentation, and continuity assurances that are critical to clinical and pharmaceutical customers.

An additional competitive axis is the degree of support and training provided. Vendors that offer comprehensive validation kits, hands-on training, and integration assistance gain traction with customers who lack internal capacity for extensive method transfer. Furthermore, transparency in supply chain practices, quality systems, and documentation is increasingly important, as buyers weigh the operational and compliance risks associated with vendor selection. Overall, companies that can combine robust technical performance with supply reliability and strong customer support are best positioned to meet the diverse needs of contemporary laboratories.

Actionable strategic recommendations for suppliers and laboratory leaders to enhance resilience, streamline validation, and accelerate adoption of advanced sample preparation solutions

Industry leaders should prioritize strategies that enhance operational resilience, promote technological interoperability, and reduce validation friction for end users. First, investing in modular automation platforms that support multiple extraction and library preparation chemistries will enable customers to adapt workflows without wholesale hardware replacement, thereby protecting installed bases and reducing procurement barriers. Such modularity should be complemented by open interfaces and software APIs to simplify integration with laboratory information systems and analytics pipelines.

Second, suppliers and buyers alike should collaborate on validation toolkits and standardized protocols that shorten adoption timelines. Providing side-by-side performance data, ready-to-run validation packs, and thorough documentation helps clinical and research laboratories achieve equivalence faster and with lower risk. In addition, developing training programs and remote support capabilities will reduce the operational burden on customers and improve long-term satisfaction.

Third, supply chain strategies must evolve to mitigate geopolitical and tariff-related disruptions. Diversifying manufacturing footprints, establishing regional distribution buffers, and negotiating supply agreements with contingency clauses are prudent steps. Buyers should also consider multi-technology procurement approaches that permit substitution between column-based, magnetic, or precipitation methods when supply constraints or cost pressures arise, while ensuring that substitution pathways are validated for critical applications.

Finally, sustainability and lifecycle considerations are becoming business differentiators. Reducing consumable waste, optimizing reagent volumes, and offering take-back or recycling programs can lower environmental impact and appeal to customers with institutional sustainability commitments. By aligning product development, operational readiness, and customer support initiatives with these priorities, industry leaders can strengthen competitive positioning and drive long-term adoption.

A transparent and rigorously triangulated research methodology combining interviews, technical assessments, literature review, and comparative evaluation to ensure actionable and reliable insights

This analysis synthesizes primary and secondary research, technical literature, and stakeholder interviews to build an evidence-based understanding of DNA and RNA sample preparation dynamics. Primary inputs included structured interviews with laboratory directors, procurement leads, and product specialists across clinical, forensic, and research domains, supplemented by technical assessments of instrument performance and reagent robustness in representative workflows. These conversational data were complemented by careful review of peer-reviewed literature and regulatory guidance to ensure alignment with current best practices and compliance expectations.

Secondary investigation involved evaluating publicly available product specifications, vendor technical notes, and independent performance studies to triangulate claims regarding throughput, hands-on time, and compatibility across technologies. Comparative assessments prioritized reproducibility, ease of integration, and validation support as key decision criteria. Where applicable, case studies and operational anecdotes were used to illustrate practical implications of technology choices and procurement strategies.

Analytical methods emphasized cross-validation between qualitative stakeholder insights and technical documentation, with iterative refinement to identify recurring themes and pain points. Care was taken to avoid reliance on single-source assertions, and interpretive judgments were grounded in multiple corroborating inputs. The resulting methodology balances technical rigor with pragmatic relevance, ensuring that recommendations are actionable for laboratory managers, procurement officers, and strategic planners.

Concluding synthesis emphasizing the strategic importance of resilient, interoperable, and validated sample preparation practices to support reliable genomic and diagnostic outcomes

In sum, DNA and RNA sample preparation is no longer a transactional laboratory activity but a strategic domain that materially influences the quality, speed, and cost-effectiveness of downstream genomic and diagnostic workflows. Technological advances in automation and reagent chemistry have expanded capability while simultaneously raising expectations for supply continuity, validation support, and integration with digital laboratory ecosystems. As a consequence, both suppliers and end users must adopt a holistic perspective that prioritizes interoperability, traceability, and resilience.

Procurement and operational decisions should be informed by a clear understanding of product segmentation, technology trade-offs, application-specific requirements, and regional nuances. Adapting to tariff and supply-chain dynamics requires proactive planning, including diversified sourcing and collaborative supplier relationships. Ultimately, organizations that invest in modular platforms, rigorous validation toolkits, and robust supplier partnerships will be better positioned to translate sample preparation improvements into reliable diagnostic outcomes, accelerated research timelines, and sustainable operational performance.

The path forward lies in harmonizing innovation with practical implementation: enabling laboratories to harness new chemistries and automation without sacrificing compliance or continuity. By doing so, institutions can realize the full potential of nucleic acid analyses across clinical, forensic, and research applications.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. DNA-RNA Sample Preparation Market, by Product Type

  • 8.1. Instruments
    • 8.1.1. Automated Workstations
    • 8.1.2. Centrifuges
  • 8.2. Kits
    • 8.2.1. Library Preparation Kits
      • 8.2.1.1. Dna Library Kits
      • 8.2.1.2. Rna Library Kits
    • 8.2.2. Nucleic Acid Extraction Kits
  • 8.3. Reagents
    • 8.3.1. Buffers
    • 8.3.2. Enzymes

9. DNA-RNA Sample Preparation Market, by Technology

  • 9.1. Column Based
  • 9.2. Magnetic Separation
  • 9.3. Precipitation

10. DNA-RNA Sample Preparation Market, by Application

  • 10.1. Clinical Diagnostics
    • 10.1.1. Genetic Testing
    • 10.1.2. Infectious Diseases
  • 10.2. Forensics
    • 10.2.1. Dna Fingerprinting
    • 10.2.2. Rna Analysis
  • 10.3. Research
    • 10.3.1. Genomics
    • 10.3.2. Transcriptomics

11. DNA-RNA Sample Preparation Market, by End User

  • 11.1. Academic Institutes
    • 11.1.1. Research Institutions
    • 11.1.2. Universities
  • 11.2. Biotechnology Companies
    • 11.2.1. Biopharma Firms
    • 11.2.2. Biotech Startups
  • 11.3. Hospitals
    • 11.3.1. Clinical Labs
    • 11.3.2. Diagnostic Centers
  • 11.4. Pharmaceutical Companies
    • 11.4.1. Big Pharma
    • 11.4.2. Generic Pharma

12. DNA-RNA Sample Preparation Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. DNA-RNA Sample Preparation Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. DNA-RNA Sample Preparation Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States DNA-RNA Sample Preparation Market

16. China DNA-RNA Sample Preparation Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agilent Technologies, Inc.
  • 17.6. Akonni Biosystems, Inc.
  • 17.7. Bio-Rad Laboratories, Inc.
  • 17.8. bioMerieux S.A.
  • 17.9. Danaher Corporation
  • 17.10. F. Hoffmann-La Roche Ltd
  • 17.11. Illumina, Inc.
  • 17.12. Merck KGaA
  • 17.13. New England Biolabs, Inc.
  • 17.14. Norgen Biotek Corp.
  • 17.15. Omega Bio-tek, Inc.
  • 17.16. PerkinElmer, Inc.
  • 17.17. Promega Corporation
  • 17.18. QIAGEN N.V.
  • 17.19. Sage Science, Inc.
  • 17.20. Takara Bio Inc.
  • 17.21. Tecan Group Ltd.
  • 17.22. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED WORKSTATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA LIBRARY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA LIBRARY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA LIBRARY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA LIBRARY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY NUCLEIC ACID EXTRACTION KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY NUCLEIC ACID EXTRACTION KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY NUCLEIC ACID EXTRACTION KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BUFFERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BUFFERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BUFFERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COLUMN BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC SEPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC SEPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY MAGNETIC SEPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRECIPITATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRECIPITATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRECIPITATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENETIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENETIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA FINGERPRINTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA FINGERPRINTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DNA FINGERPRINTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RNA ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TRANSCRIPTOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TRANSCRIPTOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOPHARMA FIRMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOPHARMA FIRMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOPHARMA FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECH STARTUPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECH STARTUPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECH STARTUPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIG PHARMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIG PHARMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIG PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENERIC PHARMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENERIC PHARMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GENERIC PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 251. GLOBAL DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 268. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 269. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 271. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 272. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 273. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 274. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 275. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 277. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 278. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 279. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 281. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 282. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 283. GCC DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY RESEARCH, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 302. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 303. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY KITS, 2018-2032 (USD MILLION)
  • TABLE 304. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION KITS, 2018-2032 (USD MILLION)
  • TABLE 305. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS DNA-RNA SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS DNA-RNA SAMPLE PREPARATION MAR